Committee approves private‑insurance parity bill requiring coverage for detransition care
Get AI-powered insights, summaries, and transcripts
Subscribe
Summary
HB 258 would require private insurers that cover transition treatments to also cover detransition‑related care; the committee passed the bill with a 9‑4 vote after adopting an effective‑date amendment to allow insurers operational lead time.
The House Health and Human Services Committee voted to favorably recommend HB 258, a bill that would require private insurers that choose to cover transition‑related procedures to also cover care associated with detransition. Sponsors said the measure is intended to ensure parity and provide a path for people who later need reversal or re‑treatment.
Supporters, including some detransition advocates and the sponsor, cited studies and anecdotal evidence that detransition and care disengagement occur and that those patients can face significant, ongoing medical needs. Do No Harm Action’s Kurt Miceli urged the committee to recognize the medical needs of detransitioners.
Opponents and insurance representatives warned that forcing insurers to shoulder care on both sides could raise premiums and impose administrative complexity; the Independent Agents association said costs could be significant and shared across all policyholders.
The committee adopted a small amendment to set a practical effective date and then voted 9‑4 to advance HB 258, with Representatives Ward, Daley‑Provost, Fitzsmanu and Hollins recorded as voting no.
Outcome and next step: HB 258 as amended was favorably recommended out of committee and will advance in the legislative process.